Michael Nagle / Xinhua / Getty Images Microcap shares perform just as well as some investors’ favorite, but at much cheaper ratings, James Paulsen, chief investment strategist at The Leuthold Group, noted in a note. The “powerful microcaps” outperformed their tech peers and even the S&P 500’s Growth Index, despite …
Read More »Day traders in Brazil study would have done better with 9 to 5 jobs
Shares ignore Stimulus Rift, worried concerns on Wall Street
COVID-19 fax maker CureVac nearly triples Nasdaq debut
Shares of German biotechnology company CureVac nearly third in their Nasdaq debut Friday, marking the first stock market debut of a company developing a potential vaccine to combat the new coronavirus. The stock opened at $ 44 per share, up from the initial public offering price of $ 16 per …
Read More »